3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Skin Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Colonic Polyps
1
Colonic Neoplasms
1
Colonic Diseases
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
trimebutine 3-thiocarbamoylbenzenesulfonate
2
pembrolizumab
2
Oxaliplatin
2
Cyclophosphamide
2
pralsetinib
1
napabucasin
1
ibrutinib
1
guadecitabine
1
XELOX
1
Sutures
1
Surgical Instruments
1
Polyethylene Glycols
1
Optical Imaging
1
Ocoxin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Control Groups
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bevacizumab
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Diseases
×
Optical Imaging
×
Clear all
NCT03139942
2019-04-16
OPTIC
Imperial College London
Phase NA
Completed
13 enrolled